SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hyperlane is an open-source, permissionless framework for blockchain interoperability. Today, it connects over 170 blockchains and supports 5+ virtual machines, powering hundreds of interchain applications on a daily basis—from asset bridges and cross-chain governance to emerging DeFi use cases. But beyond its current role as an interchain messaging protocol, we see Hyperlane evolving into a global network for transferring value—a decentralized infrastructure layer that would serve as the technical backbone of a modern digital payment network.

Hyperchain

Hyperchain is experiencing a surge in market interest and community activity, fueled by its potential for cross-chain scaling and integration with broader DeFi ecosystems. Investors are actively discussing its technical developments, including recent partnership activity and the expectation of upcoming growth cycles.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quant (QNT) is drawing attention as investors highlight its institutional utility in tokenization and cross-chain infrastructure, with many in the community viewing it as a long-term 'sleeper' play due to its limited token supply. Despite skepticism from some traders regarding recent price stagnation, bullish participants are actively discussing potential catalysts like upcoming staking, enterprise integration, and its role in banking projects.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

HYPE is currently trending as a major topic of conversation due to intense market activity and record liquidation data that has spurred significant price discovery. The community is focused on the token's infrastructure utility and its performance on the Hyperliquid exchange, often comparing its growth trajectory to major legacy assets.

Fortinet Inc. The Group's principal activity is to provide network security appliances and Unified Threat Management (UTM) network security solutions to enterprises, service providers and government entities worldwide. The solutions are designed to integrate multiple levels of security protection, including firewall, virtual private networking, antivirus, intrusion prevention, web filtering, antispam and WAN acceleration. The Group has operations in the Americas; Europe, the Middle East and Africa; and Asia Pacific and Japan.

Fortinet Inc

Fortinet is seeing significant investor attention following a breakdown to new all-time highs, driven by strong momentum in cybersecurity demand and enterprise spending resilience. Community discussions are centered on the stock's role as a high-beta infrastructure leader, with many traders closely monitoring its technical performance and debating its valuation relative to emerging AI-focused security competitors.

Hyliion Holdings Corp. engages in the development of sustainable electricity-producing technology. It focuses on providing modular power plant technology that can operate on various fuel sources through the KARNO power module. The company was founded by Thomas J. Healy in 2015 and is headquartered in Cedar Park, TX.

Hyliion Holdings Corporation - Ordinary Shares - Class A

Hyliion Holdings Corp

Hyliion Holdings is rallying behind significant momentum in its KARNO power generator technology, which is being positioned as a key solution for the massive energy demands of AI data centers and military applications. The community is buzzing over recent UL certification milestones, upcoming military sea trials, and potential institutional interest, all fueling active discussions about the company's transition from research to commercial-scale deployment.

Voyager Technologies, Inc. engages in the defense technology and space solutions. It operates through the following segments: Defense & National Security, Space Solutions, and Starlab Space Stations. The Defense & National Security segment consists of innovative mission-critical solutions to protect dynamic and contested domains. The Space Solutions segment consists of space infrastructure, advanced space technology, science systems and mission services. The Starlab Space Stations segment consists of a commercial space station. The company was founded by Dylan Taylor and Matthew Kuta on August 15, 2019 and is headquartered in Denver, CO.

Voyager Technologies Inc. - Ordinary Shares - Class A

Voyager Technologies is drawing intense investor attention due to its central role in developing Starlab to replace the International Space Station and its securing of recurring NASA and defense subcontracts. The community is actively debating the company's valuation against the broader space sector momentum, with many users highlighting the potential for significant long-term growth as Voyager pivots toward critical orbital infrastructure and national security projects.

Ascent Solar Technologies, Inc. engages in the design, development, and manufacture of photovoltaic solar modules. It integrates photovoltaic modules into a variety of applications such as aerospace, defense, transportation, and electronic products. The company was founded by Mohan S. Misra and Joseph H. Armstrong on October 18, 2005 and is headquartered in Thornton, CO.

Ascent Solar Technologies Inc

Ascent Solar Technologies is trending as investors speculate on its potential role in the growing space infrastructure market, fueled by recent partnerships and interest in space-based solar power solutions. While bulls highlight potential catalysts from NASA and the broader space-defense sector, skeptics remain wary of the company's historical financial performance and reliance on dilution.

Alaska Air Group, Inc. is a holding company, which engages in the provision of air transportation services. It operates through the following segments: Alaska Airlines, Hawaiian Airlines, and Regional. The Alaska Airlines segment includes scheduled air transportation on Alaska's Boeing and Airbus jet aircraft for passengers and cargo. The Hawaiian Airlines segment refers to scheduled air transportation on Hawaiian's Boeing and Airbus aircraft for passengers and cargo. The Regional segment consists of Horizon's and other third-party carriers’ scheduled air transportation on E175 aircraft for passengers under CPAs. The company was founded in 1985 and is headquartered in Seattle, WA.

Alaska Air Group Inc.

Alaska Air Group is capturing significant attention as investors monitor a potential deal that has reached final stages, combined with recent institutional buying activity and bullish analyst sentiment regarding international expansion. The community is actively discussing strong travel demand and route growth, though some conversations remain cautious due to ongoing fuel cost volatility and geopolitical developments in the region.

The Campbell's Co. engages in the business of manufacturing and marketing food and beverage products. It operates under the Meals and Beverages, and Snacks segments. The Meals and Beverages segment includes soup, meals, and beverage products in retail and foodservice. The Snacks segment offers cookies, crackers, bakery, and frozen products. The company was founded by Joseph Campbell and Abraham Anderson in 1869 and is headquartered in Camden, NJ.

Campbells Co (The)

Campbell Soup Co.

Campbell Soup Co. is trending as investors aggressively accumulate the stock, viewing it as a defensive, high-yield opportunity that has reached generational value levels. Community sentiment is heavily focused on potential M&A activity, institutional accumulation, and the stock's status as an undervalued staple play despite ongoing sector-wide headwinds like tariff impacts and input costs.

The TROLL token on the Solana network is a meme coin inspired by internet trolling culture, designed for entertainment and community engagement with no intrinsic value. Built on Solana’s blockchain, it leverages the network’s fast transactions and low fees to appeal to meme enthusiasts. Launched on decentralized exchanges, TROLL aims to foster a fun, community-driven ecosystem through social media, influencer partnerships, and viral marketing, embodying the playful spirit of online trolling.

Troll

Troll (TROLL) is trending as investors react to its recent Coinbase listing and optimistic technical setups, with community members drawing parallels to other high-profile meme coin cycles. Discussions are heavily focused on the coin's perceived cultural durability as an original meme and speculative excitement regarding potential future tier-one exchange listings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Galmed Announces Results from First-in-Man Pharmacokinetics Study of Oral Formulation of Aramchol Meglumine (AM); 400mg AM Increases Bioavailability by ~500% in Comparison to Aramchol Free Acid (AA) 300mg

Galmed Announces Results from First-in-Man Pharmacokinetics Study of Oral Formulation of Aramchol Meglumine (AM); 400mg AM Increases Bioavailability by ~500% in Comparison to Aramchol Free Acid (AA...

Tissue Dynamics and Galmed Pharmaceuticals to Develop Human-Centered Chronic Cardiac Fibrosis Platform to Advance Aramchol-Based Therapeutics

Tissue Dynamics and Galmed Pharmaceuticals to Develop Human-Centered Chronic Cardiac Fibrosis Platform to Advance Aramchol-Based Therapeutics Tissue Dynamics and Galmed Pharmaceuticals to Develop...

Galmed Announces a Collaboration Agreement with Tel Aviv University to Evaluate its SCD1 inhibitor, Aramchol, as a Targeted Therapy for Metastatic Brain Cancers

Galmed Announces a Collaboration Agreement with Tel Aviv University to Evaluate its SCD1 inhibitor, Aramchol, as a Targeted Therapy for Metastatic Brain Cancers Galmed Announces a Collaboration Agreement with Tel Aviv University to Evaluate its SCD1 inhibitor, Aramchol, as a Targeted Therapy for...

Galmed Stock Soars On Brain-Penetrating Aramchol Formulation

Galmed Pharmaceuticals Ltd. shares are trading higher after it announced the development of a brain penetrating new formulation of Aramchol.read more...

These Stocks are Turning Heads

A wave of innovation across AI robotics, biotechnology, advanced materials, and clean energy is reshaping the small-cap landscape. $ONCO, $KBLB, $ELAB, $GLMD, $TURB, $GAME

GLMD Stock Shot Up 55% Today After Rising 27% In 5 Days – What’s The Latest On Its Parkinson’s Disease Therapy?

Equity

The biotech firm launched a new formulation of its investigational therapy, which could help treat Parkinson’s disease.

Galmed Announces the Breakthrough Development of a Brain Penetrating New Formulation of its SCD1 inhibitor, Aramchol

Galmed Announces the Breakthrough Development of a Brain Penetrating New Formulation of its SCD1 inhibitor, Aramchol Galmed Announces the Breakthrough Development of a Brain Penetrating New...

Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025

Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025 Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended...

Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification

Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification PR Newswire TEL AVIV, Israel, Jan...

Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting

Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting PR...

Galmed Pharmaceuticals Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.

Current Price	$0.5801
Prev Close	$0.5801
Open	$0.5773
Dividend Yield	0.00%
50-Day Moving Average	$0.6151
Beta	1.36
Avg. Volume	8.87M
PE Ratio	-0.25

52-Week High	$2.34
52-Week Low	$0.4111
Market Capitalization	$3.83M
EPS (Annual)	-$2.39
Price to Book	0.24
Revenue Per Employee	$0.00

GLMD
Galmed Pharmaceuticals Ltd

Feed

News

Sentiment

Fundamentals

Info

Compact View

Latest GLMD News

GLMDGalmed Pharmaceuticals Ltd